MoneyWorks4Me

Biocon informs about company statement

04 Mar 2024 Evaluate

Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Biologics Secures Canada Market Entry Date for YESAFILI®, a Proposed Biosimilar to EYLEA®’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1791.95
Dr. Reddys Labs. 1200.55
Cipla 1323.45
Lupin 2001.10
Zydus Lifesciences 1135.00
View more..